NF-κΒ activator 1 is a potent NF-κΒ activator with an EC50 of 0.9 μM and induces superoxide dismutase (SOD)2 mRNA expression.
NF-κΒ activator 1 is a potent NF-κΒ activator with an EC50 of 0.9 μM and induces superoxide dismutase (SOD)2 mRNA expression.
CWI1-2 is an IGF2BP2 inhibitor that binds IGF2BP2 and inhibits its interaction with m6A-modified target transcripts, induces apoptosis and differentiation, and possesses anti-leukemic activity.
CWI1-2 is an IGF2BP2 inhibitor that binds IGF2BP2 and inhibits its interaction with m6A-modified target transcripts, induces apoptosis and differentiation, and possesses anti-leukemic activity.
CWI1-2 hydrochloride is an IGF2BP2 inhibitor that binds IGF2BP2 and inhibits its interaction with m6A-modified target transcripts, induces apoptosis and differentiation, and possesses anti-leukemic activity.
CWI1-2 is an IGF2BP2 inhibitor that binds IGF2BP2 and inhibits its interaction with m6A-modified target transcripts, induces apoptosis and differentiation, and possesses anti-leukemic activity.
Polyvinyl alcohol (PVA) is a versatile water-soluble polymer that can be used in studies related to drug delivery.
Hymeglusin is a β-lactone antibiotic with antifungal activity and an HMG-CoA synthase inhibitor with an IC50 value of 0.12 μM, which can inhibit HMG-CoA synthase by covalently modifying the active Cys129 residue of the enzyme.
Melittin is a PLA2 activator that stimulates the activity of low molecular weight PLA2 without increasing the activity of high molecular weight PLA2.
GsMTx4 TFA is a spider venom peptide that selectively inhibits cation permeable mechanosensitive channels (MSCs) belonging to the Piezo and TRP channel families. In addition, GsMTx4 TFA blocks cation-selective stretch-activated channels (SACs) and attenuates lysophosphatidylcholine (LPC)-induced astrocytotoxicity and microglial cell reactivity.
AP 811 is a selective atrial natriuretic peptide clearance receptor (ANP-CR, NPR3) antagonist with a Ki of 0.48 nM.